Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Sep 20;31(1):38–44. doi: 10.1158/1055-9965.EPI-21-0380

Figure 2.

Figure 2.

Expected number of women exposed to unnecessary confirmation tests per cancer detected (top row) and per life saved (bottom row) associated with adding specific cancers to an existing test for breast cancer at specific screening ages (columns) assuming specificity of the two-cancer test is 99%, 15-year incidence-based mortality from the Surveillance, Epidemiology, and End Results program, and the mortality reduction associated with screening for each cancer is 5% (light bars), 10% (medium bars), or 20% (dark bars).